{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:02:45Z","timestamp":1786132965530,"version":"build-2736575974"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1681\/asn.2015010091","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T21:51:17Z","timestamp":1434405077000},"page":"2930-2937","source":"Crossref","is-referenced-by-count":82,"title":["Complete and Partial Remission as Surrogate End Points in Membranous Nephropathy"],"prefix":"10.1681","volume":"26","author":[{"given":"Aliza","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Cattran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Blank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Nachman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20230208","first-page":"697","article-title":"The clinical course of idiopathic membranous nephropathy.","volume":"48","author":"Erwin","year":"1973","journal-title":"Mayo Clin Proc"},{"key":"R2-9-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-78-1-1","article-title":"Membranous glomerulonephritis. Evolution of clinical and pathologic features.","volume":"78","author":"Gluck","year":"1973","journal-title":"Ann Intern Med"},{"key":"R3-9-20230208","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2215\/CJN.01330209","article-title":"The natural history of the non-nephrotic membranous nephropathy patient.","volume":"4","author":"Hladunewich","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R4-9-20230208","first-page":"19","article-title":"Management of membranous nephropathy.","volume":"54","author":"Cattran","year":"2002","journal-title":"Minerva Urol Nefrol"},{"key":"R5-9-20230208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/0002-9343(79)90486-8","article-title":"Long-term prognosis of idiopathic membranous glomerulonephritis. Study of 116 untreated patients.","volume":"66","author":"Noel","year":"1979","journal-title":"Am J Med"},{"key":"R6-9-20230208","first-page":"61","article-title":"The natural history of renal function in untreated idiopathic membranous glomerulonephritis in adults.","volume":"22","author":"Davison","year":"1984","journal-title":"Clin Nephrol"},{"key":"R7-9-20230208","first-page":"793","article-title":"The natural history of membranous nephropathy in the West of Scotland.","volume":"60","author":"MacTier","year":"1986","journal-title":"Q J Med"},{"key":"R8-9-20230208","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ki.1988.56","article-title":"Idiopathic membranous nephropathy: The natural history of untreated patients.","volume":"33","author":"Donadio","year":"1988","journal-title":"Kidney Int"},{"key":"R9-9-20230208","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy.","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R10-9-20230208","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMc076523","article-title":"The normal hematocrit study\u2014follow-up.","volume":"358","author":"Besarab","year":"2008","journal-title":"N Engl J Med"},{"key":"R11-9-20230208","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin.","volume":"339","author":"Besarab","year":"1998","journal-title":"N Engl J Med"},{"key":"R12-9-20230208","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease.","volume":"355","author":"Singh","year":"2006","journal-title":"N Engl J Med"},{"key":"R13-9-20230208","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N Engl J Med"},{"key":"R14-9-20230208","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/0272-6386(95)90058-6","article-title":"Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins.","volume":"26","author":"Zoja","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R15-9-20230208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000020640","article-title":"Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators.","volume":"7","author":"Zoja","year":"1999","journal-title":"Exp Nephrol"},{"key":"R16-9-20230208","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/ndt\/16.9.1769","article-title":"Regulation of endothelin-1 and transforming growth factor-beta1 production in cultured proximal tubular cells by albumin and heparan sulphate glycosaminoglycans.","volume":"16","author":"Yard","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R17-9-20230208","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1681\/ASN.V1061204","article-title":"Induction of monocyte chemoattractant protein-1 by albumin is mediated by nuclear factor kappaB in proximal tubule cells.","volume":"10","author":"Wang","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R18-9-20230208","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI16079","article-title":"Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo.","volume":"111","author":"Tang","year":"2003","journal-title":"J Clin Invest"},{"key":"R19-9-20230208","doi-asserted-by":"crossref","first-page":"F1397","DOI":"10.1152\/ajprenal.90313.2008","article-title":"Complement activation by tubular cells is mediated by properdin binding.","volume":"295","author":"Gaarkeuken","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"R20-9-20230208","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ki.1994.59","article-title":"Alternative pathway activation of complement by cultured human proximal tubular epithelial cells.","volume":"45","author":"Biancone","year":"1994","journal-title":"Kidney Int"},{"key":"R21-9-20230208","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1681\/ASN.2006040377","article-title":"How does proteinuria cause progressive renal damage?","volume":"17","author":"Abbate","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R22-9-20230208","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/ndt\/gfm919","article-title":"The impact of sex in primary glomerulonephritis.","volume":"23","author":"Cattran","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R23-9-20230208","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/ki.1992.374","article-title":"Predicting chronic renal insufficiency in idiopathic membranous glomerulonephritis.","volume":"42","author":"Pei","year":"1992","journal-title":"Kidney Int"},{"key":"R24-9-20230208","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/ki.1995.453","article-title":"A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy.","volume":"48","author":"Ponticelli","year":"1995","journal-title":"Kidney Int"},{"key":"R25-9-20230208","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy.","volume":"25","author":"Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"key":"R26-9-20230208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1056\/NEJM198901053200102","article-title":"A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.","volume":"320","author":"Ponticelli","year":"1989","journal-title":"N Engl J Med"},{"key":"R27-9-20230208","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1681\/ASN.V93444","article-title":"A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.","volume":"9","author":"Ponticelli","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R28-9-20230208","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy.","volume":"329","author":"Schieppati","year":"1993","journal-title":"N Engl J Med"},{"key":"R29-9-20230208","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.ajkd.2005.10.016","article-title":"A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy.","volume":"47","author":"Ponticelli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R30-9-20230208","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1523-1755.2004.00873.x","article-title":"Idiopathic membranous nephropathy: Definition and relevance of a partial remission.","volume":"66","author":"Troyanov","year":"2004","journal-title":"Kidney Int"},{"key":"R31-9-20230208","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.ki.5002215","article-title":"Tacrolimus monotherapy in membranous nephropathy: A randomized controlled trial.","volume":"71","author":"Praga","year":"2007","journal-title":"Kidney Int"},{"key":"R32-9-20230208","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1046\/j.1523-1755.2001.0590041484.x","article-title":"Cyclosporine in patients with steroid-resistant membranous nephropathy: A randomized trial.","volume":"59","author":"Cattran","year":"2001","journal-title":"Kidney Int"},{"key":"R33-9-20230208","first-page":"85","article-title":"Remissions and relapses in idiopathic membranous nephropathy.","volume":"7","author":"Ponticelli","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"R34-9-20230208","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0272-6386(99)70138-1","article-title":"Prognosis after a complete remission in adult patients with idiopathic membranous nephropathy.","volume":"33","author":"Laluck","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R35-9-20230208","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1681\/ASN.2012020181","article-title":"Rituximab in idiopathic membranous nephropathy.","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R36-9-20230208","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/gfu306","article-title":"Predictors of response and relapse in patients with idiopathic membranous nephropathy treated with tacrolimus.","volume":"30","author":"Caro","year":"2015","journal-title":"Nephrol Dial Transplant"},{"key":"R37-9-20230208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2215\/CJN.07570712","article-title":"Immunosuppression for membranous nephropathy: A systematic review and meta-analysis of 36 clinical trials.","volume":"8","author":"Chen","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R38-9-20230208","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199208273270904","article-title":"Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy.","volume":"327","author":"Ponticelli","year":"1992","journal-title":"N Engl J Med"},{"key":"R39-9-20230208","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1056\/NEJM198404123101503","article-title":"Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy.","volume":"310","author":"Ponticelli","year":"1984","journal-title":"N Engl J Med"},{"key":"R40-9-20230208","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1681\/ASN.2007020166","article-title":"A randomized, controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy.","volume":"18","author":"Jha","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R41-9-20230208","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0140-6736(12)61566-9","article-title":"Immunosuppression for progressive membranous nephropathy: A UK randomised controlled trial.","volume":"381","author":"Howman","year":"2013","journal-title":"Lancet"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:42Z","timestamp":1786130802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201512000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2015010091","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}